IMCIVREE® (setmelanotide) injection –
NOW FDA-APPROVED FOR
A NEW INDICATION > Learn More

Components Testing

Delivering rare impact for patients and families

Developing precision medicines for previously untreatable diseases

Science

Using science to transform the lives of patients living with rare neuroendocrine diseases

NOW FDA-
APPROVED
FOR A NEW INDICATION

press release

You are about to leave Rhythm Pharmaceuticals.

Go BACK